Solid Biosciences (SLDB) PT Raised to $10 at Nomura/Instinet
Tweet
Share
E-mailGet Alerts SLDB Hot Sheet
Price: $9.08 -0.22%
Rating Summary:
16 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
16 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Nomura/Instinet analyst Christopher Marai raised the price target on Solid Biosciences (NASDAQ: SLDB) to $10.00 (from $6.00) while maintaining a Buy rating.
- Expression Data: SGT-001 Positive Risk/Benefit
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at H.C. Wainwright
- Duos Technologies Group (DUOT) PT Raised to $27 at Cantor Fitzgerald on 'Extremely Attractive' Risk/Reward
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
NomuraSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
